Published in Ann Surg on October 01, 1983
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut (2002) 2.16
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Selection of operation for esophageal cancer based on staging. Ann Surg (1986) 2.03
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut (1992) 1.96
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China. PLoS One (2014) 1.53
Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study. J Clin Pathol (1984) 1.24
Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer (1999) 1.22
Histological and histochemical changes in the columnar lined (Barrett's) oesophagus. Gut (1986) 1.15
Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer (1992) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg (1991) 1.13
Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus. Gut (1993) 1.12
The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut (1993) 1.11
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut (2000) 1.10
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut (1992) 1.08
Pathogenesis of columnar-lined esophagus. World J Gastroenterol (2006) 1.02
Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence. Gut (1996) 1.01
p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci (1997) 1.01
The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann Surg (2007) 1.00
Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut (1994) 0.99
Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci (1997) 0.97
Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc (2006) 0.96
Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol (2009) 0.95
Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus. Gut (1989) 0.95
Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci (1998) 0.94
Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg (2004) 0.93
Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci (2000) 0.92
Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia. Neoplasia (1999) 0.89
Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese. World J Gastroenterol (2004) 0.88
Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg (2001) 0.87
Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol (2005) 0.85
Surgical treatment of Barrett's esophagus: 1980-2003. World J Surg (2004) 0.84
Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up. Ann Surg (2002) 0.84
Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg (1993) 0.83
Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg (1997) 0.83
High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus. PLoS One (2015) 0.81
Expression of resistin-like molecule beta in Barrett's esophagus: a novel biomarker for metaplastic epithelium. Dig Dis Sci (2009) 0.79
Columnar epithelial lined oesophagus (CELO) or Barrett's oesophagus: mucin histochemistry, dysplasia, and invasive adenocarcinoma. J Clin Pathol (1985) 0.78
A substantial incidence of silent short segment endoscopically suspected esophageal metaplasia in an adult Japanese primary care practice. World J Gastrointest Endosc (2012) 0.78
Normalized autofluorescence imaging diagnostics in upper GI tract: a new method to improve specificity in neoplasia detection. Int J Clin Exp Pathol (2012) 0.77
Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases. World J Surg (2002) 0.77
Barrett's oesophagus and adenocarcinoma. World J Surg Oncol (2004) 0.76
Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus. Gastroenterol Res Pract (2012) 0.76
Esophagogastrectomy for benign esophageal stricture. Fate of the esophagogastric anastomosis. Ann Surg (1987) 0.75
Surveillance in Barrett's oesophagus: a personal view. Postgrad Med J (2002) 0.75
[Barrett's esophagus. An update]. Pathologe (2012) 0.75
Barrett's esophagus: model of neoplastic progression. World J Surg (2003) 0.75
The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future. BMJ Case Rep (2009) 0.75
Barrett esophagus: history, definition and etiopathogeny. J Med Life (2014) 0.75
Short-Segment Barrett's Esophagus and Adenocarcinoma. Gastroenterol Hepatol (N Y) (2006) 0.75
Barrett's oesophagus. Postgrad Med J (1998) 0.75
Three cases of adenocarcinoma arising in extremely long-segment Barrett's esophagus. Dig Dis Sci (2006) 0.75
Multiple early esophageal cancers arising from Barrett's esophagus, and a review of cases of early adenocarcinoma in Barrett's esophagus in Japan. J Gastroenterol (1997) 0.75
Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg (1950) 9.92
Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol (1974) 5.89
Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients. J Thorac Cardiovasc Surg (1967) 4.67
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
Gastropexy and "fundoplication" in surgical treatment of hiatal hernia. Am J Dig Dis (1961) 3.65
Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg (1975) 2.92
The histologic spectrum of Barrett's esophagus. N Engl J Med (1976) 2.84
En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg (1983) 2.78
The oesophagus lined with gastric mucous membrane. Thorax (1953) 2.74
RECONSTRUCTION OF THE ESOPHAGUS WITH LEFT COLON. J Thorac Cardiovasc Surg (1965) 2.57
Assessment of distal esophageal function in patients with hiatal hernia and-or gastroesophageal reflux. Ann Surg (1970) 2.55
The lower esophagus lined by columnar epithelium. Surgery (1957) 2.14
Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol (1978) 2.13
Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery (1970) 1.80
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
The lower esophagus lined by columnar epithelium. Its association with hiatal hernia, ulcer, stricture, and tumor. J Thorac Cardiovasc Surg (1963) 1.42
Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology (1977) 1.37
The columnar-lined esophagus (Barrett syndrome)--an acquired condition? Gastroenterology (1966) 1.30
Barrett's esophagus: a review. Am J Med (1983) 1.27
Barrett syndrome. Case report with discussion about concepts of pathogenesis. Gastroenterology (1960) 1.22
Adenocarcinoma of the oesophagus and ectopic gastric mucosa. Br J Cancer (1952) 1.20
The treatment of fibrous stricture of the oesophagus associated with hiatal hernia. Thorax (1961) 1.10
Malignant transformation of esophageal columnar epithelium. Cancer (1978) 0.99
Adenocarcinoma of the esophagus arising in aberrant gastric mucosa. Am Surg (1955) 0.99
Barrett esophagus. Arch Surg (1977) 0.93
Barrett's esophagus. Surg Gynecol Obstet (1983) 0.85
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients. J Thorac Cardiovasc Surg (1967) 4.67
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Trimethoprim as an additional selective agent in media for the isolation of N. gonorrhoeae. J Clin Pathol (1970) 3.92
EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol (1997) 3.75
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet (2000) 3.73
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun (2000) 3.66
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
The chromodomain protein Swi6: a key component at fission yeast centromeres. Science (1995) 3.40
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem (1993) 3.23
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Acid clearing from the distal esophagus. Arch Surg (1968) 3.04
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience (1999) 2.84
En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg (1983) 2.78
Illusory conjunctions in the perception of objects. Cogn Psychol (1982) 2.78
Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology (1981) 2.75
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
Occult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg (1997) 2.70
Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J Clin Microbiol (2002) 2.62
Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol (1999) 2.61
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Assessment of distal esophageal function in patients with hiatal hernia and-or gastroesophageal reflux. Ann Surg (1970) 2.55
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology (1996) 2.53
Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae. Br J Vener Dis (1973) 2.53
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS (1999) 2.47
Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell (1999) 2.45
Predicting acute maxillary sinusitis in a general practice population. BMJ (1995) 2.44
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol (1993) 2.43
Granulomatous mastitis: a report of seven cases. J Clin Pathol (1982) 2.35
Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict (1999) 2.34
Do gender differences exist in pacemaker implantation?--results of an obligatory external quality control program. Europace (2009) 2.30
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
[Non-surgical removal of a knotted Swan-Ganz catheter]. Anaesthesist (1991) 2.16
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol (1994) 2.08
Testing the porphyrinogenicity of propofol in a primed rat model. Br J Anaesth (1995) 2.08
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
AmpG, a signal transducer in chromosomal beta-lactamase induction. Mol Microbiol (1993) 2.06
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol (1995) 2.04
Selection of operation for esophageal cancer based on staging. Ann Surg (1986) 2.03
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet (1991) 2.02
Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun (2000) 2.01
Nucleotide sequence analysis of enteropathogenic Escherichia coli (EPEC) adherence factor probe and development of PCR for rapid detection of EPEC harboring virulence plasmids. J Clin Microbiol (1994) 2.01
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Early surgery for acute gallstone pancreatitis: evaluation of a systematic approach. Surgery (1978) 1.98
The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology (1999) 1.97
The solitary ulcer syndrome of the rectum. Clin Gastroenterol (1975) 1.97
Etiology and pathogenesis of acute biliary pancreatitis. Surgery (1980) 1.96
[Investigations of the penicillin concentration in the serum following benzyl penicillin sodium in massive doses. With reference to the treatment of gonorrhea in Greenland]. Ugeskr Laeger (1965) 1.96
The fission yeast rad22 gene, having a function in mating-type switching and repair of DNA damages, encodes a protein homolog to Rad52 of Saccharomyces cerevisiae. Nucleic Acids Res (1993) 1.94
Symptomatic esophageal reflux. Am J Dig Dis (1966) 1.91
Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J Clin Microbiol (2000) 1.90
Management of esophageal perforation. Am J Surg (1980) 1.90
Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78-11. Mol Microbiol (1995) 1.89
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc Natl Acad Sci U S A (1988) 1.86
A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun (1999) 1.86
Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol (1998) 1.83
Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG (2006) 1.83
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology (1999) 1.80
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int (2000) 1.79
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol (1999) 1.77
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis (2004) 1.73
Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. J Med Microbiol (1995) 1.73
[The effect of tetraethylammonium chloride on single Ranvier's nodes]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 1.71
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol (1994) 1.69
Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl Environ Microbiol (1996) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Mössbauer studies of alkane omega-hydroxylase: evidence for a diiron cluster in an integral-membrane enzyme. Proc Natl Acad Sci U S A (1997) 1.67